Article
CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemia.
Annals of hematology - 2 May 2026
Nie Jinhong, Gao Lu, Shao Yingchun, Yang Li, Cao Junjie, Xu Jinge, Wang Yuhang, Zhang Yuqi, Cui Tong, Zhou Shiyuan, Zhu Wenjuan, Zhu Mingqing, Ma Xiao, Wu Depei, Wu Xiaojin
Abstract excerpt
Acute myeloid leukemia (AML) blasts often have high CD135 (FLT3 receptor) expression, but its clinical impact is unclear. We analyzed CD135 expression, and the clinical characteristics and outcomes of 214 patients with de novo AML diagnosed between October 2022 and May 2024. Subsequently, we collected data on additional 78 patients, diagnosed with AML at four medical centers from June to December 2024, for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
